Oura IPO draws heavy demand, oversubscribed fourfold ahead of Nasdaq market debut.

Oura’s planned Nasdaq IPO has drawn orders for roughly four times the shares available, a strong showing amid a subdued U.S. listing market in which other companies have postponed offerings. The company and existing shareholders are offering 50 million shares at $40 to $44 each, potentially raising up to $2.2 billion; Oura plans to sell 13.5 million shares, with investors including Forerunner Ventures and Lifeline Ventures selling the remaining 36.5 million. At the top of the range, Oura would have an estimated market capitalization of about $14.1 billion, or roughly $15 billion on a fully diluted basis, and is scheduled to price the offering September 29 under the ticker OURA.
Goldman Sachs, Morgan Stanley, JPMorgan, Allen & Co. and Jefferies are leading the offering.
The banks running the deal were expected to stop accepting investor orders on Monday afternoon, while discussions were still ongoing and the terms could change.
Oura has broadened its ring’s focus beyond sleep and activity monitoring, adding features for heart health, stress, recovery and wider wellness tracking.
Bloomberg data cited in the articles indicate Oura’s offering could be the first U.S. IPO to raise more than $1 billion since Jersey Mike’s Subs went public in July.
Publishers
12
Articles
67
Reach
79